Cressey BD, Belum VR, Scheinman P, Silvestri D, McEntee N, Livingston V, Lacouture ME, Zippin JH, et al.
Contact dermatitis. Date of publication 2017 Jan 1;volume 76(1):27-33.
1. Contact Dermatitis. 2017 Jan;76(1):27-33. doi: 10.1111/cod.12678. Epub 2016 Aug
31.
Stoma care products represent a common and previously underreported source of
peristomal contact dermatitis.
Cressey BD(1), Belum VR(2), Scheinman P(3)(4), Silvestri D(5), McEntee N(6),
Livingston V(6), Lacouture ME(2), Zippin JH(1).
Author information:
(1)Department of Dermatology, Weill Cornell Medical Center and New
York-Presbyterian Hospital, New York, NY 10065, USA.
(2)Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer
Center, New York, NY 10022, USA.
(3)Department of Dermatology, Tufts Medical Center, Boston, MA 02111, USA.
(4)Department of Dermatology, Brigham and Women's Hospital, Boston, MA 02115,
USA.
(5)Division of Dermatology, Department of Medicine, University of Massachusetts
Medical School, Worcester, MA 01605, USA.
(6)Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial
Sloan-Kettering Cancer Center, New York, NY 10065, USA.
BACKGROUND: Peristomal dermatitis is a common complication for the >700 000
patients in the United States with an ostomy. The role of stoma skin care
products in peristomal dermatitis is poorly understood.
OBJECTIVE: To evaluate stoma skin care products as a cause of peristomal
dermatitis.
METHODS: A retrospective chart review of patients with peristomal dermatitis at
four academic hospitals from January 2010 to March 2014 was performed. Patient
demographics, clinical information and use test and patch test results were
documented.
RESULTS: Eighteen patients identified as having peristomal dermatitis were
tested. Twelve of these had peristomal contact dermatitis. We identified numerous
stoma skin care products as triggers of irritant and/or allergic contact
dermatitis. The most common stoma skin care product used and/or involved in
dermatitis was Cavilon™ No Sting Barrier Film.
CONCLUSIONS: Our data support a paradigm shift whereby healthcare workers
treating patients with peristomal dermatitis, which is currently considered to be
a reaction mainly to bodily fluids, must consider those products used to protect
the skin as potential triggers for this disease. Therefore, patients with
peristomal dermatitis should be tested with their stoma skin care agents to
determine the need for removal or change of these products. Additionally, full
ingredient labelling by manufacturers would help identify new allergens and
irritants.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
DOI: 10.1111/cod.12678
PMCID: PMC5523875
PMID: 27576564 [Indexed for MEDLINE]
